Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1529319

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1529319

Asia Pacific Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Asia Pacific Peripheral Artery Disease Market would witness market growth of 7.8% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Peripheral Artery Disease Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $541.2 million by 2031. The Japan market is registering a CAGR of 7.1% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 8.4% during (2024 - 2031).

The aging population not only drives the prevalence of PAD but also highlights the need for comprehensive care and effective treatment strategies. Older adults are more susceptible to PAD and its associated risk factors, necessitating ongoing monitoring and management. The increasing number of elderly individuals with PAD places additional demands on healthcare systems, emphasizing the need for effective and innovative treatments.

Increased healthcare spending, especially in developing countries, is another factor enabling the widespread adoption of PAD treatments. Governments and private sector investors recognize the importance of building robust healthcare infrastructures to address the growing burden of chronic diseases, including PAD. Increased healthcare expenditure facilitates greater access to advanced medical technologies and therapies, improving patient outcomes and driving market growth.

In Japan, more than 1 in 10 people are now aged 80 or older, and the country consistently rates as having the world's oldest population. The Japanese government has been promoting early diagnosis and comprehensive treatment of PAD through national health policies and programs. Efforts include increasing public awareness about the disease and providing advanced medical care options to manage and treat PAD effectively. Similarly, the Australian government has been implementing public health initiatives to address these issues, including the National Tobacco Strategy and the Healthy Weight Guide, which aim to reduce smoking rates and promote healthy lifestyles. Additionally, there is a focus on improving early diagnosis and treatment options for PAD to manage the growing healthcare burden. Therefore, the APAC market is expected to grow significantly due to the abovementioned factors.

Based on Product Type, the market is segmented into Drugs (Antiplatelet Medicines, Statins, Anti Hypertensive Medication, and Others), and Devices (Peripheral Stents, Peripheral Angioplasty Balloons, Peripheral Catheters, Plaque Modification Devices, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, and Peripheral Accessories). Based on End User, the market is segmented into Hospitals, and Specialty Clinics. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Becton, Dickinson and Company
  • Bayer AG
  • Koninklijke Philips N.V.
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Biotronik SE & Co. KG

Asia Pacific Peripheral Artery Disease Market Report Segmentation

By Product Type

  • Drugs
    • Antiplatelet Medicines
    • Statins
    • Anti Hypertensive Medication
    • Others
  • Devices
    • Peripheral Stents
    • Peripheral Angioplasty Balloons
    • Peripheral Catheters
    • Plaque Modification Devices
    • Inferior Vena Cava Filters
    • Hemodynamic Flow Alteration Devices
    • Peripheral Accessories

By End User

  • Hospitals
  • Specialty Clinics

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Peripheral Artery Disease Market, by Product Type
    • 1.4.2 Asia Pacific Peripheral Artery Disease Market, by End User
    • 1.4.3 Asia Pacific Peripheral Artery Disease Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Peripheral Artery Disease Market by Product Type

  • 4.1 Asia Pacific Drugs Market by Country
  • 4.2 Asia Pacific Peripheral Artery Disease Market by Drugs Type
    • 4.2.1 Asia Pacific Antiplatelet Medicines Market by Country
    • 4.2.2 Asia Pacific Statins Market by Country
    • 4.2.3 Asia Pacific Anti Hypertensive Medication Market by Country
    • 4.2.4 Asia Pacific Others Market by Country
  • 4.3 Asia Pacific Devices Market by Country
  • 4.4 Asia Pacific Peripheral Artery Disease Market by Devices Type
    • 4.4.1 Asia Pacific Peripheral Stents Market by Country
    • 4.4.2 Asia Pacific Peripheral Angioplasty Balloons Market by Country
    • 4.4.3 Asia Pacific Peripheral Catheters Market by Country
    • 4.4.4 Asia Pacific Plaque Modification Devices Market by Country
    • 4.4.5 Asia Pacific Inferior Vena Cava Filters Market by Country
    • 4.4.6 Asia Pacific Hemodynamic Flow Alteration Devices Market by Country
    • 4.4.7 Asia Pacific Peripheral Accessories Market by Country

Chapter 5. Asia Pacific Peripheral Artery Disease Market by End User

  • 5.1 Asia Pacific Hospitals Market by Country
  • 5.2 Asia Pacific Specialty Clinics Market by Country

Chapter 6. Asia Pacific Peripheral Artery Disease Market by Country

  • 6.1 China Peripheral Artery Disease Market
    • 6.1.1 China Peripheral Artery Disease Market by Product Type
      • 6.1.1.1 China Peripheral Artery Disease Market by Drugs Type
      • 6.1.1.2 China Peripheral Artery Disease Market by Devices Type
    • 6.1.2 China Peripheral Artery Disease Market by End User
  • 6.2 Japan Peripheral Artery Disease Market
    • 6.2.1 Japan Peripheral Artery Disease Market by Product Type
      • 6.2.1.1 Japan Peripheral Artery Disease Market by Drugs Type
      • 6.2.1.2 Japan Peripheral Artery Disease Market by Devices Type
    • 6.2.2 Japan Peripheral Artery Disease Market by End User
  • 6.3 India Peripheral Artery Disease Market
    • 6.3.1 India Peripheral Artery Disease Market by Product Type
      • 6.3.1.1 India Peripheral Artery Disease Market by Drugs Type
      • 6.3.1.2 India Peripheral Artery Disease Market by Devices Type
    • 6.3.2 India Peripheral Artery Disease Market by End User
  • 6.4 South Korea Peripheral Artery Disease Market
    • 6.4.1 South Korea Peripheral Artery Disease Market by Product Type
      • 6.4.1.1 South Korea Peripheral Artery Disease Market by Drugs Type
      • 6.4.1.2 South Korea Peripheral Artery Disease Market by Devices Type
    • 6.4.2 South Korea Peripheral Artery Disease Market by End User
  • 6.5 Singapore Peripheral Artery Disease Market
    • 6.5.1 Singapore Peripheral Artery Disease Market by Product Type
      • 6.5.1.1 Singapore Peripheral Artery Disease Market by Drugs Type
      • 6.5.1.2 Singapore Peripheral Artery Disease Market by Devices Type
    • 6.5.2 Singapore Peripheral Artery Disease Market by End User
  • 6.6 Malaysia Peripheral Artery Disease Market
    • 6.6.1 Malaysia Peripheral Artery Disease Market by Product Type
      • 6.6.1.1 Malaysia Peripheral Artery Disease Market by Drugs Type
      • 6.6.1.2 Malaysia Peripheral Artery Disease Market by Devices Type
    • 6.6.2 Malaysia Peripheral Artery Disease Market by End User
  • 6.7 Rest of Asia Pacific Peripheral Artery Disease Market
    • 6.7.1 Rest of Asia Pacific Peripheral Artery Disease Market by Product Type
      • 6.7.1.1 Rest of Asia Pacific Peripheral Artery Disease Market by Drugs Type
      • 6.7.1.2 Rest of Asia Pacific Peripheral Artery Disease Market by Devices Type
    • 6.7.2 Rest of Asia Pacific Peripheral Artery Disease Market by End User

Chapter 7. Company Profiles

  • 7.1 Becton, Dickinson, and Company
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Bayer AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 SWOT Analysis
  • 7.3 Koninklijke Philips N.V.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Acquisition and Mergers:
    • 7.3.6 SWOT Analysis
  • 7.4 Abbott Laboratories
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Acquisition and Mergers:
    • 7.4.6 SWOT Analysis
  • 7.5 Terumo Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expenses
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Product Launches and Product Expansions:
    • 7.5.6 SWOT Analysis
  • 7.6 B. Braun Melsungen AG
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 SWOT Analysis
  • 7.7 Medtronic PLC
    • 7.7.1 Company overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expenses
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Acquisition and Mergers:
    • 7.7.6 SWOT Analysis
  • 7.8 Boston Scientific Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Acquisition and Mergers:
    • 7.8.6 SWOT Analysis
  • 7.9 Cardinal Health, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 SWOT Analysis
  • 7.10. Biotronik SE & Co. KG
    • 7.10.1 Company Overview
    • 7.10.2 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Asia Pacific Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 2 Asia Pacific Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 3 Asia Pacific Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 4 Asia Pacific Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 5 Asia Pacific Drugs Market by Country, 2020 - 2023, USD Million
  • TABLE 6 Asia Pacific Drugs Market by Country, 2024 - 2031, USD Million
  • TABLE 7 Asia Pacific Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 8 Asia Pacific Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 9 Asia Pacific Antiplatelet Medicines Market by Country, 2020 - 2023, USD Million
  • TABLE 10 Asia Pacific Antiplatelet Medicines Market by Country, 2024 - 2031, USD Million
  • TABLE 11 Asia Pacific Statins Market by Country, 2020 - 2023, USD Million
  • TABLE 12 Asia Pacific Statins Market by Country, 2024 - 2031, USD Million
  • TABLE 13 Asia Pacific Anti Hypertensive Medication Market by Country, 2020 - 2023, USD Million
  • TABLE 14 Asia Pacific Anti Hypertensive Medication Market by Country, 2024 - 2031, USD Million
  • TABLE 15 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 16 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 17 Asia Pacific Devices Market by Country, 2020 - 2023, USD Million
  • TABLE 18 Asia Pacific Devices Market by Country, 2024 - 2031, USD Million
  • TABLE 19 Asia Pacific Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 20 Asia Pacific Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 21 Asia Pacific Peripheral Stents Market by Country, 2020 - 2023, USD Million
  • TABLE 22 Asia Pacific Peripheral Stents Market by Country, 2024 - 2031, USD Million
  • TABLE 23 Asia Pacific Peripheral Angioplasty Balloons Market by Country, 2020 - 2023, USD Million
  • TABLE 24 Asia Pacific Peripheral Angioplasty Balloons Market by Country, 2024 - 2031, USD Million
  • TABLE 25 Asia Pacific Peripheral Catheters Market by Country, 2020 - 2023, USD Million
  • TABLE 26 Asia Pacific Peripheral Catheters Market by Country, 2024 - 2031, USD Million
  • TABLE 27 Asia Pacific Plaque Modification Devices Market by Country, 2020 - 2023, USD Million
  • TABLE 28 Asia Pacific Plaque Modification Devices Market by Country, 2024 - 2031, USD Million
  • TABLE 29 Asia Pacific Inferior Vena Cava Filters Market by Country, 2020 - 2023, USD Million
  • TABLE 30 Asia Pacific Inferior Vena Cava Filters Market by Country, 2024 - 2031, USD Million
  • TABLE 31 Asia Pacific Hemodynamic Flow Alteration Devices Market by Country, 2020 - 2023, USD Million
  • TABLE 32 Asia Pacific Hemodynamic Flow Alteration Devices Market by Country, 2024 - 2031, USD Million
  • TABLE 33 Asia Pacific Peripheral Accessories Market by Country, 2020 - 2023, USD Million
  • TABLE 34 Asia Pacific Peripheral Accessories Market by Country, 2024 - 2031, USD Million
  • TABLE 35 Asia Pacific Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 36 Asia Pacific Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 37 Asia Pacific Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 38 Asia Pacific Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 39 Asia Pacific Specialty Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 40 Asia Pacific Specialty Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 41 Asia Pacific Peripheral Artery Disease Market by Country, 2020 - 2023, USD Million
  • TABLE 42 Asia Pacific Peripheral Artery Disease Market by Country, 2024 - 2031, USD Million
  • TABLE 43 China Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 44 China Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 45 China Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 46 China Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 47 China Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 48 China Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 49 China Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 50 China Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 51 China Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 52 China Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 53 Japan Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 54 Japan Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 55 Japan Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 56 Japan Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 57 Japan Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 58 Japan Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 59 Japan Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 60 Japan Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 61 Japan Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 62 Japan Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 63 India Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 64 India Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 65 India Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 66 India Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 67 India Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 68 India Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 69 India Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 70 India Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 71 India Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 72 India Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 73 South Korea Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 74 South Korea Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 75 South Korea Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 76 South Korea Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 77 South Korea Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 78 South Korea Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 79 South Korea Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 80 South Korea Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 81 South Korea Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 82 South Korea Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 83 Singapore Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 84 Singapore Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 85 Singapore Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 86 Singapore Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 87 Singapore Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 88 Singapore Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 89 Singapore Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 90 Singapore Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 91 Singapore Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 92 Singapore Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 93 Malaysia Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 94 Malaysia Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 95 Malaysia Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 96 Malaysia Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 97 Malaysia Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 98 Malaysia Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 99 Malaysia Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 100 Malaysia Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 101 Malaysia Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 102 Malaysia Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 103 Rest of Asia Pacific Peripheral Artery Disease Market, 2020 - 2023, USD Million
  • TABLE 104 Rest of Asia Pacific Peripheral Artery Disease Market, 2024 - 2031, USD Million
  • TABLE 105 Rest of Asia Pacific Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
  • TABLE 106 Rest of Asia Pacific Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
  • TABLE 107 Rest of Asia Pacific Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
  • TABLE 108 Rest of Asia Pacific Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
  • TABLE 109 Rest of Asia Pacific Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
  • TABLE 110 Rest of Asia Pacific Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
  • TABLE 111 Rest of Asia Pacific Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
  • TABLE 112 Rest of Asia Pacific Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
  • TABLE 113 Key Information - Becton, Dickinson and Company
  • TABLE 114 Key Information - Bayer AG
  • TABLE 115 Key Information - Koninklijke Philips N.V.
  • TABLE 116 Key Information - Abbott Laboratories
  • TABLE 117 Key Information - Terumo Corporation
  • TABLE 118 Key Information - B. Braun Melsungen AG
  • TABLE 119 Key Information - Medtronic PLC
  • TABLE 120 Key Information - Boston Scientific Corporation
  • TABLE 121 key information - Cardinal Health, Inc.
  • TABLE 122 Key Information - Biotronik SE & Co. KG
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!